Your browser doesn't support javascript.
loading
Excisional treatment comparison for in situ endocervical adenocarcinoma (EXCISE): A phase 2 pilot randomized controlled trial to compare histopathological margin status, specimen size and fragmentation after loop electrosurgical excision procedure and cold knife cone biopsy.
Cohen, Paul A; Leung, Yee; Anderson, Lyndal; van der Griend, Rachael; Chivers, Paola; Bilic, Sanela; Bittinger, Sophie; Brand, Alison; Bulsara, Max K; Codde, Jim; Eva, Lois; Farrell, Louise; Harker, Dianne; Herbst, Unine; Jeffares, Stephanie; Loh, Diane; McNally, Orla; Mohan, Ganendra Raj; Nicholson, Tarryn; Powell, Aime; Salfinger, Stuart G; Simcock, Bryony; Stewart, Colin; Silvers, Julie; Stockler, Martin R; Sykes, Peter; Stoyles, Pennie; Tan, Adeline; Tan, Ai Ling; Wrede, C David H.
Afiliação
  • Cohen PA; Division of Obstetrics and Gynaecology, University of Western Australia, Crawley, Western Australia, Australia; Dept of Gynaecological Oncology, St John of God Hospital, Subiaco, Western Australia, Australia; Dept of Gynaecological Oncology, King Edward Memorial Hospital, Subiaco, Western Australia,
  • Leung Y; Division of Obstetrics and Gynaecology, University of Western Australia, Crawley, Western Australia, Australia; Dept of Gynaecological Oncology, King Edward Memorial Hospital, Subiaco, Western Australia, Australia; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Aus
  • Anderson L; Sydney Medical School, The University of Sydney, New South Wales, Australia; School of Medicine, Western Sydney University, Penrith South, New South Wales, Australia; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia.
  • van der Griend R; Department of Anatomical Pathology, Canterbury Health Laboratories, Christchurch, New Zealand.
  • Chivers P; Institute for Health Research, University of Notre Dame Australia, Fremantle, Western Australia, Australia; Exercise Medicine Research Institute, Edith Cowan University, Joondalup, Western Australia, Australia.
  • Bilic S; Dept of Gynaecological Oncology, St John of God Hospital, Subiaco, Western Australia, Australia; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia.
  • Bittinger S; Oncology and Dysplasia Unit, The Royal Women's Hospital, Melbourne, Victoria, Australia.
  • Brand A; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia; Discipline of Obstetrics and Gynaecology, University of Sydney, Sydney, New South Wales, Australia.
  • Bulsara MK; Institute for Health Research, University of Notre Dame Australia, Fremantle, Western Australia, Australia.
  • Codde J; Institute for Health Research, University of Notre Dame Australia, Fremantle, Western Australia, Australia; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia.
  • Eva L; Dept of Gynaecological Oncology, National Women's Health, Auckland City Hospital, Auckland, New Zealand; Department of Gynaecological Oncology, University of Auckland, Auckland, New Zealand; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia.
  • Farrell L; Dept of Gynaecological Oncology, King Edward Memorial Hospital, Subiaco, Western Australia, Australia.
  • Harker D; Department of Obstetrics and Gynaecology, Univeristy of Otago, Christchurch, New Zealand.
  • Herbst U; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia.
  • Jeffares S; Dept of Gynaecological Oncology, St John of God Hospital, Subiaco, Western Australia, Australia; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia.
  • Loh D; Division of Obstetrics and Gynaecology, University of Western Australia, Crawley, Western Australia, Australia; Dept of Gynaecological Oncology, King Edward Memorial Hospital, Subiaco, Western Australia, Australia.
  • McNally O; Oncology and Dysplasia Unit, The Royal Women's Hospital, Melbourne, Victoria, Australia; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Victoria, Australia.
  • Mohan GR; Dept of Gynaecological Oncology, St John of God Hospital, Subiaco, Western Australia, Australia; Dept of Gynaecological Oncology, King Edward Memorial Hospital, Subiaco, Western Australia, Australia; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia.
  • Nicholson T; Dept of Gynaecological Oncology, National Women's Health, Auckland City Hospital, Auckland, New Zealand.
  • Powell A; Institute for Health Research, University of Notre Dame Australia, Fremantle, Western Australia, Australia; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia.
  • Salfinger SG; Dept of Gynaecological Oncology, St John of God Hospital, Subiaco, Western Australia, Australia; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia.
  • Simcock B; Department of Obstetrics and Gynaecology, Univeristy of Otago, Christchurch, New Zealand; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia; Christchurch Womens Hospital, Christchurch, New Zealand.
  • Stewart C; Division of Obstetrics and Gynaecology, University of Western Australia, Crawley, Western Australia, Australia; PathWest, King Edward Memorial Hospital, Subiaco, Western Australia, Australia.
  • Silvers J; Oncology and Dysplasia Unit, The Royal Women's Hospital, Melbourne, Victoria, Australia.
  • Stockler MR; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, New South Wales, Australia; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia.
  • Sykes P; Department of Obstetrics and Gynaecology, Univeristy of Otago, Christchurch, New Zealand; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia; Christchurch Womens Hospital, Christchurch, New Zealand.
  • Stoyles P; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia.
  • Tan A; Clinipath Pathology, Osborne Park, Western Australia, Australia.
  • Tan AL; Dept of Gynaecological Oncology, National Women's Health, Auckland City Hospital, Auckland, New Zealand; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia.
  • Wrede CDH; Oncology and Dysplasia Unit, The Royal Women's Hospital, Melbourne, Victoria, Australia; Australia New Zealand Gynaecological Oncology Group, Camperdown, New South Wales, Australia; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Victoria, Australia.
Gynecol Oncol ; 159(3): 623-629, 2020 12.
Article em En | MEDLINE | ID: mdl-33032824
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Neoplasias do Colo do Útero / Eletrocirurgia / Adenocarcinoma in Situ Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline Limite: Adult / Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Neoplasias do Colo do Útero / Eletrocirurgia / Adenocarcinoma in Situ Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline Limite: Adult / Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos